16-765195-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005823.6(MSLN):c.596A>T(p.Glu199Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000037 in 1,592,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005823.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSLN | NM_005823.6 | c.596A>T | p.Glu199Val | missense_variant | 9/18 | ENST00000545450.7 | NP_005814.2 | |
MSLN | NM_013404.4 | c.596A>T | p.Glu199Val | missense_variant | 8/17 | NP_037536.2 | ||
MSLN | NM_001177355.3 | c.596A>T | p.Glu199Val | missense_variant | 9/18 | NP_001170826.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSLN | ENST00000545450.7 | c.596A>T | p.Glu199Val | missense_variant | 9/18 | 1 | NM_005823.6 | ENSP00000442965 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000667 AC: 14AN: 210014Hom.: 0 AF XY: 0.0000690 AC XY: 8AN XY: 115994
GnomAD4 exome AF: 0.0000361 AC: 52AN: 1440580Hom.: 0 Cov.: 34 AF XY: 0.0000391 AC XY: 28AN XY: 716354
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.596A>T (p.E199V) alteration is located in exon 8 (coding exon 7) of the MSLN gene. This alteration results from a A to T substitution at nucleotide position 596, causing the glutamic acid (E) at amino acid position 199 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at